Panel Discussion | Can We and Should We Skip TEE for LAA Closure? Role of CT and ICE?

Saturday, March 8, 2025

11:46 AM - 12:10 PM ET

Moderator(s)

Creighton W. Don, MD

Professor of Medicine/Cardiology Director of the Interventional Cardiology and Structural Heart Fellowships
University of Washington
Seattle, Washington, United States

No relationships to disclose
Antonio Frangieh, MD

Medical Director Structural Heart Program, Associate Professor of Medicine
University Of California Irvine
Orange, California, United States

Disclosure(s): Edward Lifesciences: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Jacqueline Saw, MD

Clinical Professor
University of British Columbia, British Columbia, Canada

No relationships to disclose

Panel Discussant(s)

Scott M. Chadderdon, MD

Associate Professor
OHSU
PORTLAND, Oregon, United States

No relationships to disclose
Tarun Chakravarty, MD

Associate Professor, Interventional Cardiology
Cedars-Sinai Medical Center
Los Angeles, California, United States

No relationships to disclose
Chetan Huded, MD, MSc

Associate Medical Director, Structural Intervention
Saint Luke's Mid America Heart Institute
Kansas City, Missouri, United States

No relationships to disclose
Uzoma N. Ibebuogu, MD

Professor of Medicine
University of Tennessee
Memphis , Tennessee, United States

No relationships to disclose
Nabil Dib, MD, MSc, FACC

Director Cardiovascular Research
Mercy Gilbert Medical Center/Dignity Health
Gilbert, Arizona, United States

No relationships to disclose
Creighton W. Don, MD

Professor of Medicine/Cardiology Director of the Interventional Cardiology and Structural Heart Fellowships
University of Washington
Seattle, Washington, United States

No relationships to disclose
Tilak K. R Pasala, MD

Medical Director, Structural Heart Program
Delray Medical Center
Orlando, Florida, United States

Disclosure information not submitted.
TP

Tai Pham, MD

Assistant Clinical Professor
University of California, Davis
Sacramento, California, United States

Disclosure(s): Abbott Vascular,: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Adona Medical, Inc.: Consultant (Ongoing); Supira Medical: Consultant (Ongoing)

Disclosure(s):

Creighton W. Don, MD: No financial relationships to disclose

Antonio Frangieh, MD: Edward Lifesciences: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Jacqueline Saw, MD: Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing)

Scott M. Chadderdon, MD: Edward Lifesciences: Consultant (Ongoing); Medtronic Inc: Consulting Fees (e.g., advisory boards) (Ongoing)

Tarun Chakravarty, MD: Cedars-Sinai Medical Center: Employee (Ongoing); Edwards Lifesciences: Consultant (Ongoing)

Chetan Huded, MD, MSc: Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Terminated)

Uzoma N. Ibebuogu, MD: No financial relationships to disclose

Nabil Dib, MD, MSc, FACC, FESC: Dib UltraNav Medical, LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Sunil V. Mankad, MD: No financial relationships to disclose

Tilak K. R Pasala, MD: No financial relationships to disclose

Tai Pham, MD: Abbott Vascular,: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Adona Medical, Inc.: Consultant (Ongoing); Supira Medical: Consultant (Ongoing)